Mitochondrial longevity pathways

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 4, 2011, Pages 634-644

  Vendelbo, M H ^a   Nair, K S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Caloric restriction; Lifespan; Longevity; Mitochondria; Oxidative damage; ROS

Indexed keywords

DNA; LIPID; PROTEIN; REACTIVE OXYGEN METABOLITE;

AGING; CALORIC RESTRICTION; CELL STRESS; ENVIRONMENTAL FACTOR; GENETIC MANIPULATION; LIFESPAN; LONGEVITY; MITOCHONDRION; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LONGEVITY; MITOCHONDRIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 79952653644     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.029     Document Type: Review

References (232)

1. Harman D. The biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 1972, 20(4):145-147.
2. Linnane A.W., et al. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1(8639):642-645.
3. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
4. Greenberg E.R., et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N. Engl. J. Med. 1994, 331(3):141-147.
5. Gaziano J.M., et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009, 301(1):52-62.
6. Liu S., et al. Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999, 282(11):1073-1075.
7. Sesso H.D., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300(18):2123-2133.
8. Bardia A., et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin. Proc. 2008, 83(1):23-34.
9. Bairati I., et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J. Natl Cancer Inst. 2005, 97(7):481-488.
10. Hercberg S., et al. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J. Nutr. 2007, 137(9):2098-2105.
11. Vivekananthan D.P., et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003, 361(9374):2017-2023.
12. Bjelakovic G., et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2008, (2):CD007176.
13. Schulz T.J., et al. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007, 6(4):280-293.
14. Ristow M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl Acad. Sci. USA 2009, 106(21):8665-8670.
15. Ristow M., Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 2010, 45(6):410-418.
16. Gomez-Cabrera M.C., et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am. J. Clin. Nutr. 2008, 87(1):142-149.
17. Wadley G.D., McConell G.K. High-dose antioxidant vitamin C supplementation does not prevent acute exercise-induced increases in markers of skeletal muscle mitochondrial biogenesis in rats. J. Appl. Physiol. 2010, 108(6):1719-1726.
18. Anderson S., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290(5806):457-465.
19. Bibb M.J., et al. Sequence and gene organization of mouse mitochondrial DNA. Cell 1981, 26(2 Pt 2):167-180.
20. Gilkerson R.W. Mitochondrial DNA nucleoids determine mitochondrial genetics and dysfunction. Int. J. Biochem. Cell Biol. 2009, 41(10):1899-1906.
21. de Souza-Pinto N.C., et al. Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res. 2001, 61(14):5378-5381.
22. Jaruga P., et al. Endogenous oxidative DNA base modifications analysed with repair enzymes and GC/MS technique. Nucleic Acids Res. 2000, 28(6):E16.
23. Hu J., et al. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J. Biol. Chem. 2005, 280(49):40544-40551.
24. Ide H., Kow Y.W., Wallace S.S. Thymine glycols and urea residues in M13 DNA constitute replicative blocks in vitro. Nucleic Acids Res. 1985, 13(22):8035-8052.
25. Clark J.M., Beardsley G.P. Functional effects of cis-thymine glycol lesions on DNA synthesis in vitro. Biochemistry 1987, 26(17):5398-5403.
26. Krokan H.E., Standal R., Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem. J. 1997, 325(Pt 1):1-16.
27. Wallace S.S. Biological consequences of free radical-damaged DNA bases. Free Radic. Biol. Med. 2002, 33(1):1-14.
28. Srivastava S., Moraes C.T. Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum. Mol. Genet. 2005, 14(7):893-902.
29. Oka S., et al. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J. 2008, 27(2):421-432.
30. Shokolenko I., et al. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 2009, 37(8):2539-2548.
31. Hatahet Z., Purmal A.A., Wallace S.S. Oxidative DNA lesions as blocks to in vitro transcription by phage T7 RNA polymerase. Ann. NY Acad. Sci. 1994, 726:346-348.
32. Short K.R., et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl Acad. Sci. USA 2005, 102(15):5618-5623.
33. Hamilton M.L., et al. Does oxidative damage to DNA increase with age?. Proc. Natl Acad. Sci. USA 2001, 98(18):10469-10474.
34. Van Remmen H., Hamilton M.L., Richardson A. Oxidative damage to DNA and aging. Exerc. Sport Sci. Rev. 2003, 31(3):149-153.
35. Trifunovic A., et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl Acad. Sci. USA 2005, 102(50):17993-17998.
36. Trifunovic A., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429(6990):417-423.
37. Sciacco M., et al. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum. Mol. Genet. 1994, 3(1):13-19.
38. Lanza I.R., et al. Endurance exercise as a countermeasure for aging. Diabetes 2008, 57(11):2933-2942.
39. Michikawa Y., et al. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999, 286(5440):774-779.
40. Calloway C.D., et al. The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increases with age. Am. J. Hum. Genet. 2000, 66(4):1384-1397.
41. Wang Y., et al. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc. Natl Acad. Sci. USA 2001, 98(7):4022-4027.
42. Del Bo R., et al. Evidence and age-related distribution of mtDNA D-loop point mutations in skeletal muscle from healthy subjects and mitochondrial patients. J. Neurol. Sci. 2002, 202(1-2):85-91.
43. Del Bo R., et al. High mutational burden in the mtDNA control region from aged muscles: a single-fiber study. Neurobiol. Aging 2003, 24(6):829-838.
44. Theves C., et al. Detection and quantification of the age-related point mutation A189G in the human mitochondrial DNA. J. Forensic Sci. 2006, 51(4):865-873.
45. McInerny S.C., Brown A.L., Smith D.W. Region-specific changes in mitochondrial D-loop in aged rat CNS. Mech. Ageing Dev. 2009, 130(5):343-349.
46. Wilson V.L., et al. Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 1987, 262(21):9948-9951.
47. Crawford D.R., Abramova N.E., Davies K.J. Oxidative stress causes a general, calcium-dependent degradation of mitochondrial polynucleotides. Free Radic. Biol. Med. 1998, 25(9):1106-1111.
48. Barazzoni R., Short K.R., Nair K.S. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J. Biol. Chem. 2000, 275(5):3343-3347.
49. Welle S., et al. Reduced amount of mitochondrial DNA in aged human muscle. J. Appl. Physiol. 2003, 94(4):1479-1484.
50. Marcus D.L., Ibrahim N.G., Freedman M.L. Age-related decline in the biosynthesis of mitochondrial inner membrane proteins. Exp. Gerontol. 1982, 17(5):333-341.
51. Marcus D.L., et al. Effect of inhibitors and stimulators on isolated liver cell mitochondrial protein synthesis from young and old rats. Exp. Gerontol. 1982, 17(6):429-435.
52. Bailey P.J., Webster G.C. Lowered rates of protein synthesis by mitochondria isolated from organisms of increasing age. Mech. Ageing Dev. 1984, 24(2):233-241.
53. Rooyackers O.E., et al. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc. Natl Acad. Sci. USA 1996, 93(26):15364-15369.
54. Bota D.A., Davies K.J. Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 2001, 1(1):33-49.
55. Henderson G.C., et al. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009, 23(2):631-641.
56. Feng J., et al. Quantitative proteomic profiling of muscle type-dependent and age-dependent protein carbonylation in rat skeletal muscle mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63(11):1137-1152.
57. Fugere N.A., Ferrington D.A., Thompson L.V. Protein nitration with aging in the rat semimembranosus and soleus muscles. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61(8):806-812.
58. Jaleel, A., et al., Identification of de novo synthesized and relatively older proteins - Accelerated oxidative damage to de novo synthesized ApoA-1 in type 1 diabetes. Diabetes.
59. Larsson L., Sjodin B., Karlsson J. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65years. Acta Physiol. Scand. 1978, 103(1):31-39.
60. Grimby G., et al. Morphology and enzymatic capacity in arm and leg muscles in 78-81year old men and women. Acta Physiol. Scand. 1982, 115(1):125-134.
61. Aniansson A., et al. Muscle morphology, enzymatic activity, and muscle strength in elderly men: a follow-up study. Muscle Nerve 1986, 9(7):585-591.
62. Trappe S.W., et al. Skeletal muscle characteristics among distance runners: a 20-yr follow-up study. J. Appl. Physiol. 1995, 78(3):823-829.
63. Rasmussen U.F., et al. Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria. Exp. Gerontol. 2003, 38(8):877-886.
64. Rasmussen U.F., et al. Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch 2003, 446(2):270-278.
65. Karakelides, H., et al., Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 59(1): 89-97.
66. Conley K.E., Jubrias S.A., Esselman P.C. Oxidative capacity and ageing in human muscle. J. Physiol. 2000, 526(Pt 1):203-210.
67. Petersen K.F., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300(5622):1140-1142.
68. Trounce I., Byrne E., Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989, 1(8639):637-639.
69. Barrientos A., et al. Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem. Biophys. Res. Commun. 1996, 229(2):536-539.
70. Brierly E.J., et al. Mitochondrial function in muscle from elderly athletes. Ann. Neurol. 1997, 41(1):114-116.
71. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 1989, 5(3):155-171. discussion 172.
72. Koubova J., Guarente L. How does calorie restriction work?. Genes Dev. 2003, 17(3):313-321.
73. Lane M.A., Ingram D.K., Roth G.S. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol. Sci. 1999, 52(2 Suppl):41-48.
74. Kemnitz J.W., et al. Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am. J. Physiol. 1994, 266(4 Pt 1):E540-E547.
75. Verdery R.B., et al. Caloric restriction increases HDL2 levels in rhesus monkeys (Macaca mulatta). Am. J. Physiol. 1997, 273(4 Pt 1):E714-E719.
76. Zainal T.A., et al. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J. 2000, 14(12):1825-1836.
77. Colman R.J., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325(5937):201-204.
78. Fontana L., et al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl Acad. Sci. USA 2004, 101(17):6659-6663.
79. Meyer T.E., et al. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 2006, 47(2):398-402.
80. Fontana, L., S. Klein, and J.O. Holloszy, Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr). 32(1): p. 97-108.
81. Holloszy J.O. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967, 242(9):2278-2282.
82. Chow L.S., et al. Impact of endurance training on murine spontaneous activity, muscle mitochondrial DNA abundance, gene transcripts, and function. J. Appl. Physiol. 2007, 102(3):1078-1089.
83. Coggan A.R., et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. J. Appl. Physiol. 1992, 72(5):1780-1786.
84. Short K.R., et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003, 52(8):1888-1896.
85. Menshikova E.V., et al. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61(6):534-540.
86. Sreekumar R., et al. Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle. Am. J. Physiol. Endocrinol. Metab. 2002, 283(1):E38-E43.
87. Sreekumar R., et al. Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am. J. Physiol. Endocrinol. Metab. 2002, 282(5):E1055-E1061.
88. Staniek K., Nohl H. Are mitochondria a permanent source of reactive oxygen species?. Biochim. Biophys. Acta 2000, 1460(2-3):268-275.
89. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120(4):483-495.
90. Nicholls D.G., Locke R.M. Thermogenic mechanisms in brown fat. Physiol. Rev. 1984, 64(1):1-64.
91. Pecqueur C., et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J. Biol. Chem. 2001, 276(12):8705-8712.
92. Richard D., et al. Distribution of the uncoupling protein 2 mRNA in the mouse brain. J. Comp. Neurol. 1998, 397(4):549-560.
93. Richard D., et al. Uncoupling protein 2 in the brain: distribution and function. Biochem. Soc. Trans. 2001, 29(Pt 6):812-817.
94. Vidal-Puig A., et al. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 1997, 235(1):79-82.
95. Boss O., et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 1997, 408(1):39-42.
96. Negre-Salvayre A., et al. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 1997, 11(10):809-815.
97. Kowaltowski A.J., Costa A.D., Vercesi A.E. Activation of the potato plant uncoupling mitochondrial protein inhibits reactive oxygen species generation by the respiratory chain. FEBS Lett. 1998, 425(2):213-216.
98. Echtay K.S., et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415(6867):96-99.
99. Echtay K.S., et al. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J. Biol. Chem. 2002, 277(49):47129-47135.
100. Murphy M.P., et al. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J. Biol. Chem. 2003, 278(49):48534-48545.
101. Brand M.D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 2000, 35(6-7):811-820.
102. Kerner J., et al. Aging skeletal muscle mitochondria in the rat: decreased uncoupling protein-3 content. Am. J. Physiol. Endocrinol. Metab. 2001, 281(5):E1054-E1062.
103. Brand M.D., et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem. J. 2002, 368(Pt 2):597-603.
104. Vidal-Puig A.J., et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 2000, 275(21):16258-16266.
105. Nabben M., et al. The effect of UCP3 overexpression on mitochondrial ROS production in skeletal muscle of young versus aged mice. FEBS Lett. 2008, 582(30):4147-4152.
106. Speakman J.R., et al. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 2004, 3(3):87-95.
107. Nicholls D.G., Ferguson S.J. Bioenergetics 3 2002, Academic Press, London.
108. Bevilacqua L., et al. Effects of short- and medium-term calorie restriction on muscle mitochondrial proton leak and reactive oxygen species production. Am. J. Physiol. Endocrinol. Metab. 2004, 286(5):E852-E861.
109. Bevilacqua L., et al. Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria. Am. J. Physiol. Endocrinol. Metab. 2005, 289(3):E429-E438.
110. Caldeira da Silva C.C., et al. Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell. 2008, 7(4):552-560.
111. Fridell Y.W., et al. Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly. Cell Metab. 2005, 1(2):145-152.
112. Andrews Z.B., Horvath T.L. Uncoupling protein-2 regulates lifespan in mice. Am. J. Physiol. Endocrinol. Metab. 2009, 296(4):E621-E627.
113. McDonald R.B., et al. Characterization of survival and phenotype throughout the life span in UCP2/UCP3 genetically altered mice. Exp. Gerontol. 2008, 43(12):1061-1068.
114. Serra V., et al. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J. Biol. Chem. 2003, 278(9):6824-6830.
115. Orr W.C., Sohal R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994, 263(5150):1128-1130.
116. Orr W.C., et al. Effects of overexpression of copper-zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster. J. Biol. Chem. 2003, 278(29):26418-26422.
117. Larsen P.L. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 1993, 90(19):8905-8909.
118. Vanfleteren J.R., De Vreese A. Rate of aerobic metabolism and superoxide production rate potential in the nematode Caenorhabditis elegans. J. Exp. Zool. 1996, 274(2):93-100.
119. Blander G., et al. Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J. Biol. Chem. 2003, 278(40):38966-38969.
120. Ho Y.S., et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 1997, 272(26):16644-16651.
121. Melov S., et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998, 18(2):159-163.
122. Reaume A.G., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996, 13(1):43-47.
123. Lebovitz R.M., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl Acad. Sci. USA 1996, 93(18):9782-9787.
124. Mecocci P., et al. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic. Biol. Med. 1999, 26(3-4):303-308.
125. Giorgio M., et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122(2):221-233.
126. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295(5564):2450-2452.
127. Trinei M., et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002, 21(24):3872-3878.
128. Migliaccio E., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402(6759):309-313.
129. Luzi L., et al. Evolution of Shc functions from nematode to human. Curr. Opin. Genet. Dev. 2000, 10(6):668-674.
130. Ravichandran K.S. Signaling via Shc family adapter proteins. Oncogene 2001, 20(44):6322-6330.
131. Yokote K., et al. Direct interaction between Shc and the platelet-derived growth factor beta-receptor. J. Biol. Chem. 1994, 269(21):15337-15343.
132. Skolnik E.Y., et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 1993, 12(5):1929-1936.
133. Migliaccio E., et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 1997, 16(4):706-716.
134. Pacini S., et al. p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells. Mol. Cell. Biol. 2004, 24(4):1747-1757.
135. Xi G., Shen X., Clemmons D.R. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment. Mol. Endocrinol. 2008, 22(9):2162-2175.
136. Xi, G., X. Shen, and D.R. Clemmons, p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation. J. Biol. Chem. 285(10): p. 6937-51.
137. Orsini F., et al. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J. Biol. Chem. 2004, 279(24):25689-25695.
138. Pinton P., et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315(5812):659-663.
139. Nemoto S., et al. The mammalian longevity-associated gene product p66shc regulates mitochondrial metabolism. J. Biol. Chem. 2006, 281(15):10555-10560.
140. Mootha V.K., et al. A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. EMBO J. 2001, 20(4):661-671.
141. Zhao Y., Wang Z.B., Xu J.X. Effect of cytochrome c on the generation and elimination of O2*- and H2O2 in mitochondria. J. Biol. Chem. 2003, 278(4):2356-2360.
142. Ow Y.P., et al. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 2008, 9(7):532-542.
143. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116(2):205-219.
144. Riedl S.J., Salvesen G.S. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007, 8(5):405-413.
145. Biggs W.H. W.K. Cavenee, and K.C. Arden, Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 2001, 12(6):416-425.
146. Jacobs F.M., et al. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 2003, 278(38):35959-35967.
147. Furuyama T., et al. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 2000, 349(Pt 2):629-634.
148. Lin K., et al. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997, 278(5341):1319-1322.
149. Ogg S., et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389(6654):994-999.
150. Henderson S.T., Johnson T.E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 2001, 11(24):1975-1980.
151. Hwangbo D.S., et al. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 2004, 429(6991):562-566.
152. Medema R.H., et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404(6779):782-787.
153. Puigserver P., et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423(6939):550-555.
154. Kim M.S., et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 2006, 9(7):901-906.
155. Bakker W.J., et al. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J. Cell Biol. 2004, 164(2):175-184.
156. Hribal M.L., et al. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J. Cell Biol. 2003, 162(4):535-541.
157. Willcox B.J., et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl Acad. Sci. USA 2008, 105(37):13987-13992.
158. Flachsbart F., et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl Acad. Sci. USA 2009, 106(8):2700-2705.
159. Kops G.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419(6904):316-321.
160. Tran H., et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002, 296(5567):530-534.
161. Dijkers P.F., et al. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell Biol. 2002, 156(3):531-542.
162. Chiba T., et al. Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice. Mech. Ageing Dev. 2009, 130(7):420-428.
163. Tatar M., Bartke A., Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003, 299(5611):1346-1351.
164. Rincon M., et al. The paradox of the insulin/IGF-1 signaling pathway in longevity. Mech. Ageing Dev. 2004, 125(6):397-403.
165. Lee S.J., Murphy C.T., Kenyon C. Glucose shortens the life span of C. elegans by downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell Metab. 2009, 10(5):379-391.
166. Kenyon C., et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366(6454):461-464.
167. Tatar M., et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 2001, 292(5514):107-110.
168. Holzenberger M., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421(6919):182-187.
169. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299(5606):572-574.
170. Brunet A., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96(6):857-868.
171. Biggs W.H., et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 1999, 96(13):7421-7426.
172. Obsilova V., et al. 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry 2005, 44(34):11608-11617.
173. Brunet A., et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002, 156(5):817-828.
174. Rena G., et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 2002, 21(9):2263-2271.
175. Zhang X., et al. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J. Biol. Chem. 2002, 277(47):45276-45284.
176. Tsai W.C., et al. Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion. Endocrinology 2003, 144(12):5615-5622.
177. Alam, H., et al., EAK-7 controls development and life span by regulating nuclear DAF-16/FoxO activity. Cell Metab. 12(1): p. 30-41.
178. Honda Y., Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 1999, 13(11):1385-1393.
179. Murakami S., Johnson T.E. The OLD-1 positive regulator of longevity and stress resistance is under DAF-16 regulation in Caenorhabditis elegans. Curr. Biol. 2001, 11(19):1517-1523.
180. Kahn B.B., et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1(1):15-25.
181. Greer E.L., et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 2007, 282(41):30107-30119.
182. Barthel A., et al. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002, 143(8):3183-3186.
183. Greer E.L., et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 2007, 17(19):1646-1656.
184. Fukuoka M., et al. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int. J. Mol. Med. 2003, 12(4):503-508.
185. Daitoku H., et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl Acad. Sci. USA 2004, 101(27):10042-10047.
186. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303(5666):2011-2015.
187. Tsai K.L., et al. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res. 2007, 35(20):6984-6994.
188. Matsuzaki H., et al. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl Acad. Sci. USA 2005, 102(32):11278-11283.
189. North B.J., Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004, 5(5):224.
190. Nemoto S., Fergusson M.M., Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306(5704):2105-2108.
191. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273(2):793-798.
192. Imai S., et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403(6771):795-800.
193. Tanner K.G., et al. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl Acad. Sci. USA 2000, 97(26):14178-14182.
194. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 2000, 14(9):1021-1026.
195. Bitterman K.J., et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 2002, 277(47):45099-45107.
196. Gallo C.M., Smith D.L., Smith J.S. Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol. Cell. Biol. 2004, 24(3):1301-1312.
197. Anderson R.M., et al. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 2003, 423(6936):181-185.
198. Balan V., et al. Life span extension and neuronal cell protection by Drosophila nicotinamidase. J. Biol. Chem. 2008, 283(41):27810-27819.
199. van der Horst A., et al. The Caenorhabditis elegans nicotinamidase PNC-1 enhances survival. Mech. Ageing Dev. 2007, 128(4):346-349.
200. Fulco M., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 2008, 14(5):661-673.
201. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 2004, 279(49):50754-50763.
202. Kim J.E., Chen J., Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008, 451(7178):583-586.
203. Escande, C., et al., Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J. Clin. Invest. 120(2): p. 545-58.
204. Kim E.J., et al. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 2007, 28(2):277-290.
205. Hasegawa K., Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J. Neurosci. 2008, 28(35):8772-8784.
206. Yang Y., et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 2007, 9(11):1253-1262.
207. Nasrin N., et al. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS ONE 2009, 4(12):e8414.
208. van der Horst A., et al. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 2004, 279(28):28873-28879.
209. Pfluger P.T., et al. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl Acad. Sci. USA 2008, 105(28):9793-9798.
210. Luo J., et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107(2):137-148.
211. Vaziri H., et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107(2):149-159.
212. Langley E., et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 2002, 21(10):2383-2396.
213. Cohen H.Y., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305(5682):390-392.
214. Lan F., et al. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283(41):27628-27635.
215. Hawley S.A., et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2(4):28.
216. Woods A., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13(22):2004-2008.
217. Tamas P., et al. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J. Exp. Med. 2006, 203(7):1665-1670.
218. Hawley S.A., et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271(44):27879-27887.
219. Canto C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009, 20(2):98-105.
220. Rodgers J.T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434(7029):113-118.
221. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127(6):1109-1122.
222. Canto, C., et al., Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell. Metab. 11(3): p. 213-9.
223. Gerhart-Hines Z., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26(7):1913-1923.
224. Aquilano, K., et al., Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. 285(28): p. 21590-9.
225. Onyango P., et al. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl Acad. Sci. USA 2002, 99(21):13653-13658.
226. Rose G., et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol. 2003, 38(10):1065-1070.
227. Kim, H.S., et al., SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 17(1): p. 41-52.
228. Lombard D.B., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27(24):8807-8814.
229. Sundaresan N.R., et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 2008, 28(20):6384-6401.
230. Pillai, V.B., et al., Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 285(5): p. 3133-44.
231. Hirschey, M.D., et al., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 464(7285): p. 121-5.
232. Sundaresan N.R., et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119(9):2758-2771.